Concomitant modulation of transcripts related to fiber type determination and energy metabolism in skeletal muscle of female ovariectomized mice by estradiol injection

Journal of Steroid Biochemistry and Molecular Biology

Volumn 122, Issue 1-3, 2010, Pages 91-99

  Riedl, Isabelle ^a   Yoshioka, Mayumi ^a   St Amand, Jonny ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Estradiol; Menopause; MRNA regulation; SAGE; Skeletal muscle

Indexed keywords

ESTRADIOL; RNA;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL METABOLIC RATE; C57BL 6 MOUSE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; METABOLIC SYNDROME X; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; SKELETAL MUSCLE; TISSUE METABOLISM; ANIMAL; BIOLOGY; C57BL MOUSE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RANDOMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPENIA;

ANIMALS; COMPUTATIONAL BIOLOGY; ENERGY METABOLISM; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; OVARIECTOMY; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SARCOPENIA; TRANSCRIPTION, GENETIC;

ANIMALIA; MUS;

EID: 77956458123     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.12.004     Document Type: Article

References (64)

1. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon M.R., Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 2003, 163(4):427-436.
2. Carr M.C. The emergence of the metabolic syndrome with menopause. J. Clin. Endocrinol. Metab. 2003, 88(6):2404-2411.
3. Salpeter S.R., Walsh J.M., Ormiston T.M., Greyber E., Buckley N.S., Salpeter E.E. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes. Metab. 2006, 8(5):538-554.
4. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288(3):321-333.
5. Dionne I.J., Kinaman K.A., Poehlman E.T. Sarcopenia and muscle function during menopause and hormone-replacement therapy. J. Nutr. Health Aging 2000, 4(3):156-161.
6. Lovejoy J.C., Champagne C.M., de Jonge L., Xie H., Smith S.R. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int. J. Obes. (Lond.) 2008, 32(6):949-958.
7. Karakelides H., Nair K.S. Sarcopenia of aging and its metabolic impact. Curr. Top. Dev. Biol. 2005, 68:123-148.
8. Harridge S.D. Plasticity of human skeletal muscle: gene expression to in vivo function. Exp. Physiol. 2007, 92(5):783-797.
9. Lexell J. Human aging, muscle mass, and fiber type composition. J. Gerontol. A: Biol. Sci. Med. Sci. 1995, 50:11-16.
10. Welle S., Bhatt K., Thornton C.A. High-abundance mRNAs in human muscle: comparison between young and old. J. Appl. Physiol. 2000, 89(1):297-304.
11. Hickey M.S., Carey J.O., Azevedo J.L., Houmard J.A., Pories W.J., Israel R.G., Dohm G.L. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am. J. Physiol. 1995, 268(3 Pt 1):E453-E457.
12. Tanner C.J., Barakat H.A., Dohm G.L., Pories W.J., MacDonald K.G., Cunningham P.R., Swanson M.S., Houmard J.A. Muscle fiber type is associated with obesity and weight loss. Am. J. Physiol. Endocrinol. Metab. 2002, 282(6):E1191-E1196.
13. Timmons J.A., Larsson O., Jansson E., Fischer H., Gustafsson T., Greenhaff P.L., Ridden J., Rachman J., Peyrard-Janvid M., Wahlestedt C., Sundberg C.J. Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. FASEB J. 2005, 19(7):750-760.
14. Piccone C.M., Brazeau G.A., McCormick K.M. Effect of oestrogen on myofibre size and myosin expression in growing rats. Exp. Physiol. 2004, 90(1):87-93.
15. McCormick K.M., Burns K.L., Piccone C.M., Gosselin L.E., Brazeau G.A. Effects of ovariectomy and estrogen on skeletal muscle function in growing rats. J. Muscle Res. Cell Motil. 2004, 25(1):21-27.
16. Velculescu V.E., Zhang L., Vogelstein B., Kinzler K.W. Serial analysis of gene expression. Science 1995, 270(5235):484-487.
17. Bolduc C., Yoshioka M., St-Amand J. Transcriptomic characterization of the long-term dihydrotestosterone effects in adipose tissue. Obesity (Silver Spring) 2007, 15(5):1107-1132.
18. Ye P., Yoshioka M., Gan L., St-Amand J. Regulation of global gene expression by ovariectomy and estrogen in female adipose tissue. Obes. Res. 2005, 13(6):1024-1030.
19. Yoshioka M., Boivin A., Ye P., Labrie F., St-Amand J. Effects of dihydrotestosterone on skeletal muscle transcriptome in mice measured by serial analysis of gene expression. J. Mol. Endocrinol. 2006, 36(2):247-259.
20. Yoshioka M., Boivin A., Bolduc C., St-Amand J. Gender difference of androgen actions on skeletal muscle transcriptome. J. Mol. Endocrinol. 2007, 39(2):119-133.
21. Delp M.D., Duan C. Composition and size of type I, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle. J. Appl. Physiol. 1996, 80(1):261-270.
22. Ustunel I., Demir R. A histochemical, morphometric and ultrastructural study of gastrocnemius and soleus muscle fiber type composition in male and female rats. Acta Anat. (Basel) 1997, 158(4):279-286.
23. St-Amand J., Okamura K., Matsumoto K., Shimizu S., Sogawa Y. Characterization of control and immobilized skeletal muscle: an overview from genetic engineering. FASEB J. 2001, 15(3):684-692.
24. Gonzalez-Zulueta M., Ensz L.M., Mukhina G., Lebovitz R.M., Zwacka R.M., Engelhardt J.F., Oberley L.W., Dawson V.L., Dawson T.M. Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J. Neurosci. 1998, 18(6):2040-2055.
25. Gygi S.P., Rochon Y., Franza B.R., Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol. 1999, 19(3):1720-1730.
26. Dinel S., Bolduc C., Belleau P., Boivin A., Yoshioka M., Calvo E., Piedboeuf B., Snyder E.E., Labrie F., St-Amand J. Reproducibility, bioinformatic analysis and power of the SAGE method to evaluate changes in transcriptome. Nucleic Acids Res. 2005, 33(3):e26.
27. Adams M.D., Kerlavage A.R., Fleischmann R.D., Fuldner R.A., Bult C.J., Lee N.H., Kirkness E.F., Weinstock K.G., Gocayne J.D., White O., Sutton G., Blake J.A., Brandon R.C., Chiu M.W., Clayton R.A., Cline R.T., Cotton M.D., Hughes J.E., Fine L.D., Fitzgerald L.M., FitzHugh W.M., Fritchman J.L., Geoghagen N.S.M., Glodek A., Gnehm C.L., Hanna M.C., Hedblom E., Hinkle P.S., Kelley J.M., Klimek K.M., Kelley J.C., Liu L.I., Marmaros S.M., Merrick J.M., Moreno-Palanques R.F., McDonald L.A., Nguyen D.T., Pellegrino S.M., Phillips C.A., Ryder S.E., Scott J.L., Saudek D.M., Shirley R., Small K.V., Spriggs T.A., Utterback T.R., Weidman J.F., Li Y., Barthlow R., Bednarik D.P., Cao L., Cepeda M.A., Coleman T.A., Collins E.J., Dimke D., Feng P., Ferrie A., Fischer C., Hastings G.A., He W.W., Hu J.S., Huddleston K.A., Greene J.M., Gruber J., Hudson P., Kim A., Kozak D.L., Kunsch C., Ji H., Li H., Meissner P.S., Olsen H., Raymond L., Wei Y.F., Wing J., Xu C., Yu G.L., Ruben S.M., Dillon P.J., Fannon M.R., Rosen C.A., Haseltine W.A., Fields C., Fraser C.M., Venter J.C. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature 1995, 377(6547 Suppl.):3-174.
28. Lash A.E., Tolstoshev C.M., Wagner L., Schuler G.D., Strausberg R.L., Riggins G.J., Altschul S.F. SAGEmap: a public gene expression resource. Genome Res. 2000, 10(7):1051-1060.
29. Hodgkinson C.P., Mander A., Sale G.J. Identification of 80K-H as a protein involved in GLUT4 vesicle trafficking. Biochem. J. 2005, 388(Pt 3):785-793.
30. DeFronzo R.A., Gunnarsson R., Björkman O., Olsson M., Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. J. Clin. Invest. 1985, 76(1):149-155.
31. Kadi F., Karlsson C., Larsson B., Eriksson J., Larval M., Billig H., Jonsdottir I.H. The effects of physical activity and estrogen treatment on rat fast and slow skeletal muscles following ovariectomy. J. Muscle Res. Cell Motil. 2002, 23(4):335-339.
32. Drewett R.F. Oestrous and dioestrous components of the ovarian inhibition on hunger in the rat. Anim. Behav. 1973, 21(4):772-780.
33. Weindruch R., Kayo T., Lee C.K., Prolla T.A. Microarray profiling of gene expression in aging and its alteration by caloric restriction in mice. J. Nutr. 2001, 131(3):918S-923S.
34. Moenter S.M., Chu Z., Christian C.A. Neurobiological mechanisms underlying oestradiol negative and positive feedback regulation of gonadotrophin-releasing hormone neurones. J. Neuroendocrinol. 2009, 21(4):327-333.
35. Bamburg J.R., Drubin D.G. Actin depolymerizing factor (ADF)/cofilin. Guidebook to the Cytoskeletal and Motor Proteins 1999, 19-24. Oxford University Press Inc., New York. T. Kreis, R. Vale (Eds.).
36. Theriot J. Accelerating on a treadmill: ADF/cofilin promotes rapid actin filament turnover in the dynamic cytoskeleton. J. Cell Biol. 1997, 136(6):1165-1168.
37. Wang K. Titin. Guidebook to the Cytoskeletal and Motor Proteins 1999, 481-486. Oxford University Press Inc., New York. T. Kreis, R. Vale (Eds.).
38. Agarkova I., Schoenauer R., Ehler E., Carlsson L., Carlsson E., Thornell L.E., Perriard J.C. The molecular composition of the sarcomeric M-band correlates with muscle fiber type. Eur. J. Cell Biol. 2004, 83(5):193-204.
39. Obermann W.M., Gautel M., Weber K., Fürst D.O. Molecular structure of the sarcomeric M band: mapping of titin and myosin binding domains in myomesin and the identification of a potential regulatory phosphorylation site in myomesin. EMBO J. 1997, 16(2):211-220.
40. Frey N., Richardson J.A., Olson E.N. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc. Natl. Acad. Sci. U.S.A. 2000, 97(26):14632-14637.
41. Delling U., Tureckova J., Lim H.W., De Windt L.J., Rotwein P., Molkentin J.D. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol. Cell Biol. 2000, 20(17):6600-6611.
42. Arber S., Halder G., Caroni P. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell 1994, 79(2):221-231.
43. Zhao X., Yoshida M., Brotto L., Takeshima H., Weisleder N., Hirata Y., Nosek T.M., Ma J., Brotto M. Enhanced resistance to fatigue and altered calcium handling properties of sarcalumenin knockout mice. Physiol. Genomics 2005, 23(1):72-78.
44. Lange S., Xiang F., Yakovenko A., Vihola A., Hackman P., Rostkova E., Kristensen J., Brandmeier B., Franzen G., Hedberg B., Gunnarsson L.G., Hughes S.M., Marchand S., Sejersen T., Richard I., Edström L., Ehler E., Udd B., Gautel M. The kinase domain of titin controls muscle gene expression and protein turnover. Science 2005, 308(5728):1599-1603.
45. Witt C.C., Burkart C., Labeit D., McNabb M., Wu Y., Granzier H., Labeit S. Nebulin regulates thin filament length, contractility, and Z-disk structure in vivo. EMBO J. 2006, 25(16):3843-3855.
46. Mizuno Y., Guyon J.R., Watkins S.C., Mizushima K., Sasaoka T., Imamura M., Kunkel L.M., Okamoto K. Beta-synemin localizes to regions of high stress in human skeletal myofibers. Muscle Nerve 2004, 30(3):337-346.
47. Teran-Garcia M., Rankinen T., Koza R.A., Rao D.C., Bouchard C. Endurance training-induced changes in insulin sensitivity and gene expression. Am. J. Physiol. Endocrinol. Metab. 2005, 288(6):E1168-E1178.
48. Okumura N., Hashida-Okumura A., Kita K., Matsubae M., Matsubara T., Takao T., Nagai K. Proteomic analysis of slow- and fast-twitch skeletal muscles. Proteomics 2005, 5(11):2896-2906.
49. Sugaya A., Sugiyama T., Yanase S., Terada Y., Toyoda N. Glucose transporter 4 (GLUT4) mRNA abundance in the adipose tissue and skeletal-muscle tissue of ovariectomized rats treated with 17 beta-estradiol or progesterone. J. Obstet. Gynaecol. Res. 1999, 25(1):9-14.
50. Sugaya A., Sugiyama T., Yanase S., Shen X.X., Minoura H., Toyoda N. Expression of glucose transporter 4 mRNA in adipose tissue and skeletal muscle of ovariectomized rats treated with sex steroid hormones. Life Sci. 2000, 66(7):641-648.
51. Sano H., Eguez L., Teruel M.N., Fukuda M., Chuang T.D., Chavez J.A., Lienhard G.E., McGraw T.E. Rab10, a target of the AS160 Rab GAP, is required for insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane. Cell Metab. 2007, 5(4):293-303.
52. Ishikura S., Bilan P.J., Klip A. Rabs 8A and 14 are targets of the insulin-regulated Rab-GAP AS160 regulating GLUT4 traffic in muscle cells. Biochem. Biophys. Res. Commun. 2006, 353(4):1074-1079.
53. Nishizawa H., Matsuda M., Yamada Y., Kawai K., Suzuki E., Makishima M., Kitamura T., Shimomura I. Musclin, a novel skeletal muscle-derived secretory factor. J. Biol. Chem. 2004, 279(19):19391-19395.
54. Barros R.P., Machado U.F., Warner M., Gustafsson J.A. Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(5):1605-1608.
55. Wiik A., Ekman M., Johansson O., Jansson E., Esbjörnsson M. Expression of both oestrogen receptor alpha and beta in human skeletal muscle tissue. Histochem. Cell Biol. 2009, 131(2):181-189.
56. Zhou D., Ye J.J., Li Y., Lui K., Chen S. The molecular basis of the interaction between the proline-rich SH3-binding motif of PNRC and estrogen receptor alpha. Nucleic Acids Res. 2006, 34(20):5974-5986.
57. Muller F.L., Song W., Liu Y., Chaudhuri A., Pieke-Dahl S., Strong R., Huang T.T., Epstein C.J., Roberts L.J., Csete M., Faulkner J.A., Van Remmen H. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic. Biol. Med. 2006, 40(11):1993-2004.
58. Elchuri S., Oberley T.D., Qi W., Eisenstein R.S., Jackson Roberts L., Van Remmen H., Epstein C.J., Huang T.T. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005, 24(3):367-380.
59. Fulle S., Di Donna S., Puglielli C., Pietrangelo T., Beccafico S., Bellomo R., Protasi F., Fanò G. Age-dependent imbalance of the antioxidative system in human satellite cells. Exp. Gerontol. 2005, 40(3):189-197.
60. Ritchie S.A., Ewart M.A., Perry C.G., Connell J.M.C., Salt I.P. The role of insulin and the adipocytokines in regulation of vascular endothelial function. Clin. Sci. 2004, 107(6):519-532.
61. Kelley D.E., Simoneau J.A. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 1994, 94(6):2349-2356.
62. Anant S., Mukhopadhyay D., Sankaranand V., Kennedy S., Henderson J.O., Davidson N.O. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing. Am. J. Physiol. Cell Physiol. 2001, 281(6):C1904-C1916.
63. Mikl M.C., Watt I.N., Lu M., Reik W., Davies S.L., Neuberger M.S., Rada C. Mice deficient in APOBEC2 and APOBEC3. Mol. Cell Biol. 2005, 25(16):7270-7277.
64. Wallace D.C. Mitochondrial diseases in man and mouse. Science 1999, 283(5407):1482-1488.